The seven-minute visit. The scan. The standardized recommendation. The next patient already waiting in the hallway before you have finished putting your shoes back on. You left feeling like a knee on a conveyor belt rather than a person.
That feeling is accurate. It is worth saying immediately that it is also not because anyone in that building dislikes you.
The line is not built to see you
The frustration you experienced is a design output, not a personal slight. The line was constructed to move volume through a defined process with predictable timing and predictable cost. Measured against that objective, it performs well.
But a system built to process volume is structurally unable to see individuals. It is not that the people inside it lack interest — it is that the format they work within provides no mechanism for individual variation to enter the decision. Seven minutes accommodates a complaint, an image, and a recommendation. It does not accommodate a history, a metabolic picture, or a question about why this joint is degrading in this person.
So the line deploys standardized tools regardless of the individual. Everyone gets the same sequence, because the sequence is the product.
The tools themselves underperform
Standardization would be a modest problem if the standardized tools were strong. They are not.
Repeated cortisone. The default first move for a painful joint, applied on a schedule, with the well-documented pattern of diminishing returns that patients experience directly.
Escalation to opioids. The step taken when the injections stop working — an escalation in intensity rather than a change in strategy.
A joint treated in isolation. Perhaps the most consequential of the three. The joint is assessed, imaged, and treated as a self-contained mechanical structure, while the metabolic terrain driving the damage is ignored entirely — not dismissed after consideration, but never brought into the frame in the first place.
Put those together and you have a sequence that can be executed flawlessly and still not change your trajectory. Which is exactly what you have lived.
Efficient at processing, ineffective at healing
That is the sentence that summarizes the whole model. The orthopedic line is genuinely efficient at processing. It is just not effective at healing.
Those are different objectives, and a system can excel at the first while performing poorly at the second without anyone inside it behaving badly. Throughput, cost per encounter, and time-to-recommendation are all optimized. Durable resolution is not among the metrics the line is tuned to.
Dr. Padda reads the orthopedic assembly line as both clinician and operator — he is a physician and an MBA, which means the analysis here is not a complaint from outside the economics. It is a description from someone who understands why the line was built this way, what pressures produced it, and what it would take to build something different.
That dual perspective is also why the critique stays aimed at structure. The conveyor belt is not the fault of the physicians standing on it. They are working inside constraints they did not set, with visit lengths, reimbursement rules, and volume expectations that determine most of what can happen in the room before anyone walks into it.
What a model built around your biology looks like
The alternative is not a better position on the belt. A shorter wait, a more attentive specialist, or a more thorough seven minutes is still the same architecture.
What changes the outcome is a different unit of analysis. Instead of a joint processed against a standard sequence, the object of attention becomes your biology — including the metabolic terrain that the line treats as out of scope. That reordering has practical consequences: assessment expands beyond the joint, measurement precedes intervention, and the tools selected follow from what was found rather than from what comes next on the protocol.
It is slower at the front end and it costs more attention. That is the trade. What it buys is the possibility that the intervention is aimed at the thing actually driving your joint’s decline.
If the seven-minute visit has left you frustrated across multiple specialists, the pattern is telling you something structural. You do not need a better spot on the belt. You need a different model.
Frequently asked questions
Does this mean my orthopedist did something wrong?
No, and that framing misses the point. The physicians working within this model are operating inside constraints they did not design — visit length, reimbursement structure, and volume expectations shape most of what is possible before anyone enters the room. The critique here is of the structure and its incentives, not of the people inside it.
Should I cancel the surgery or injections I have scheduled?
No. Do not start, stop, or change any treatment without consulting your physician. If this article raises questions about whether your evaluation was complete, bring those questions to the physician who knows your case, or seek a formal second evaluation before your date.
What specifically does the assembly line miss?
Chiefly, the metabolic terrain driving the damage. The joint is treated as an isolated mechanical structure, so the systemic conditions contributing to its degeneration are never entered into the assessment. The standardized tools — repeated cortisone, escalation to opioids — are then applied to a problem whose driver was never characterized.
How is a different model actually different in practice?
Measurement comes before intervention, the assessment extends beyond the joint to the terrain around it, and the treatment selected follows from what was found rather than from a standard sequence. Individual results vary and not every patient is a candidate for every approach; what applies to you is determined by evaluation.
Key takeaways
- The conveyor-belt experience is a design output of a system built for volume, not a reflection of anyone’s regard for you.
- The line deploys standardized tools regardless of the individual, because standardization is the product.
- Those tools underperform: repeated cortisone, escalation to opioids, and a joint treated in isolation.
- The metabolic terrain driving the damage is not dismissed — it is never brought into the frame at all.
- The line is efficient at processing and ineffective at healing; a better spot on the belt does not change that.
Medically reviewed by Gurpreet Singh Padda, MD, MBA, MHP — Board Certified in Anesthesiology, Pain Medicine, Interventional Pain Management, Addiction Medicine, and Obesity Medicine. Last reviewed July 2026.
This article is educational and is not a substitute for evaluation, diagnosis, or treatment by a physician. Individual results vary, and not every patient is a candidate for the therapies described. Do not start, stop, or change any treatment without consulting your physician.
Find out what is actually driving your pain
Regen.MD begins with a physician-led Clinical Evaluation — a review of your history, imaging, and metabolic data, and a written terrain roadmap. Evaluation is contingent upon review of your data.
Questions? Call (314) 295-3000 or text (314) 886-5902.